Core Viewpoint - The article discusses a recent study published in *Nature Metabolism* by a team from Shanghai Jiao Tong University, which demonstrates that resistant starch (RS) can significantly aid overweight or obese individuals in weight loss and metabolic health improvement through its effects on gut microbiota and metabolism [6][8]. Group 1: Research Highlights - The study integrates multi-omics analysis, combining microbiome and metabolomics data to comprehensively assess the impact of resistant starch on gut microbiota structure and human metabolism [6]. - An innovative clinical trial design was employed, utilizing a randomized, placebo-controlled, crossover approach, which effectively reduced confounding variables and enhanced the reliability of results [6]. - The research reveals that resistant starch influences multiple pathways, including bile acid metabolism, inflammation reduction, gut barrier repair, and lipid absorption inhibition, providing a new theoretical basis for future obesity prevention and treatment strategies [6][8]. Group 2: Clinical Trial Details - The study included participants aged 18 to 55 years who were overweight or obese, defined as BMI ≥ 24 kg/m² or waist circumference ≥ 85 cm for men and ≥ 80 cm for women. Exclusion criteria included acute diseases, recent antibiotic or probiotic use, and certain metabolic disorders [9]. - The trial involved 37 overweight or obese participants over an 8-week intervention period, with a 4-week washout phase between treatments. Results indicated that resistant starch effectively reduced weight, fat mass, and waist circumference while improving insulin sensitivity [11]. Group 3: Mechanisms and Findings - Resistant starch supplementation led to an increase in beneficial gut bacteria such as *Bifidobacterium* species, enhancing gut barrier function and reducing inflammation levels [11][13]. - The study found that *Bifidobacterium adolescentis* was highly correlated with reductions in BMI, waist circumference, and other metabolic markers, suggesting its critical role in alleviating obesity [14]. - Animal studies demonstrated that gut microbiota from resistant starch-fed humans could reduce obesity and improve glucose metabolism in mice, indicating the potential of RS to reshape gut microbiota for weight management [16]. Group 4: Inflammatory Response and Gut Barrier - The RS-induced gut microbiota significantly lowered systemic inflammation markers in mice, with reductions in MCP-1, IL-1β, and IL-6, while increasing anti-inflammatory IL-10 levels [18]. - The study showed that RS improved gut barrier integrity, reducing the permeability to lipopolysaccharides (LPS) and thereby alleviating obesity-related chronic inflammation [19]. Group 5: Role of *B. adolescentis* - The proliferation of *B. adolescentis* due to RS was linked to a decrease in abdominal obesity, with active *B. adolescentis* enhancing the expression of ANGPTL4, which mitigated weight gain and fat accumulation in mice [21]. - Metabolomic analysis indicated that *B. adolescentis* treatment led to a decrease in primary bile acids and an increase in secondary bile acids, contributing to improved metabolic profiles [21].

Core Viewpoint - The article discusses a recent study published in *Nature Metabolism* by a team from Shanghai Jiao Tong University, which demonstrates that resistant starch (RS) can significantly aid overweight or obese individuals in weight loss and improving metabolic health through modulation of gut microbiota and metabolic pathways [6][8]. Group 1: Research Highlights - The study integrates microbiome and metabolomics data to comprehensively assess the impact of resistant starch on gut microbiota structure and human metabolism [6]. - It employs a randomized, placebo-controlled crossover trial design, enhancing the reliability of results by minimizing confounding variables [6]. - The research reveals that resistant starch affects bile acid metabolism, reduces inflammation, repairs gut barriers, and inhibits lipid absorption, providing a new theoretical basis for obesity prevention and treatment [6][8]. Group 2: Study Methodology - The study included participants aged 18 to 55 years, classified as overweight or obese (BMI ≥ 24 kg/m²), and excluded those with acute diseases or recent antibiotic use [9]. - A randomized controlled crossover design was used to evaluate the effects of resistant starch on weight control and insulin resistance, combined with metagenomic and metabolomic techniques to analyze gut microbiota changes [10]. Group 3: Key Findings - The intervention with resistant starch resulted in significant weight loss, reduced fat mass, and improved insulin sensitivity among 37 overweight or obese participants over an 8-week period [11]. - Resistant starch increased the abundance of beneficial bacteria such as *Bifidobacterium*, enhancing gut barrier function and reducing inflammation [11][13]. - In animal models, the transplantation of gut microbiota from resistant starch-fed humans led to lower body weight and fat mass, indicating the effectiveness of RS-modulated gut microbiota in weight management [16]. Group 4: Mechanisms of Action - The study found that resistant starch-induced gut microbiota changes lowered systemic inflammation markers and improved gut barrier integrity, which is crucial for managing obesity-related chronic inflammation [18][19]. - The increase in *Bifidobacterium adolescentis* was closely linked to the alleviation of abdominal obesity, suggesting its potential role in metabolic health [21].